American Heart Journal
Volume 156, Issue 6 , Pages 1196-1200, December 2008

Ejection fraction assessment and survival: An analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

  • Lorne J. Gula, MD, MS

      Affiliations

    • University of Western Ontario, London, Ontario, Canada
    • Corresponding Author InformationReprint requests: Lorne J. Gula, MD, London Health Sciences Centre, Arrhythmia Service, 339 Windermere Road, London, Ontario, Canada N6A 5A5.
    • ,
  • George J. Klein, MD

      Affiliations

    • University of Western Ontario, London, Ontario, Canada
    • ,
  • Anne S. Hellkamp, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • David Massel, MD

      Affiliations

    • University of Western Ontario, London, Ontario, Canada
    • ,
  • Andrew D. Krahn, MD

      Affiliations

    • University of Western Ontario, London, Ontario, Canada
    • ,
  • Allan C. Skanes, MD

      Affiliations

    • University of Western Ontario, London, Ontario, Canada
    • ,
  • Raymond Yee, MD, FRCPC

      Affiliations

    • University of Western Ontario, London, Ontario, Canada
    • ,
  • Jill Anderson, RN

      Affiliations

    • Seattle Institute for Cardiac Research, Seattle, WA
    • ,
  • George W. Johnson, BSEE

      Affiliations

    • Seattle Institute for Cardiac Research, Seattle, WA
    • ,
  • Jeanne E. Poole, MD

      Affiliations

    • University of Washington Medical Center, Seattle, WA
    • ,
  • Daniel B. Mark, MD, MPH

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Kerry L. Lee, PhD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Gust H. Bardy, MD

      Affiliations

    • Seattle Institute for Cardiac Research, Seattle, WA
    • ,
  • for the SCD-HeFT Investigators

Received 29 May 2008; accepted 5 August 2008. published online 07 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 SCD-HeFT was supported by grants (UO1 HL55766, UO1 HL55297, and UO1 HL55496) from the National Heart, Lung, and Blood Institute, National Institutes of Health (both in Bethesda, MD), and by Medtronic (Minneapolis, MN), Wyeth-Ayerst Laboratories (Madison, NJ). This substudy was supported by a grant from Medtronic of Canada (Mississauga, Ontario, Canada).

 Author Disclosures: Dr Bardy: Research funding from Medtronic and Wyeth-Ayerst Pharmaceuticals; founder of, board member of, consultant to, and equity holder in Cameron Health (San Clemente, CA). Dr Gula: grant support from Medtronic of Canada. Dr Klein: consultant fees from Medtronic. Dr Krahn: consultant fees from Boston Scientific and Transoma. Dr Lee: research funding from Medtronic and Wyeth-Ayerst Pharmaceuticals. Dr Mark: grant support and speaking fees from Medtronic. Dr Poole: speaking fees from Boston Scientific (Natick, MA), Medtronic, and Biotronic (Ann Arbor, MI). Dr Yee: Consultant fees from Medtronic.

 Guest editor: Gary S. Francis, MD.

PII: S0002-8703(08)00668-6

doi:10.1016/j.ahj.2008.08.007

American Heart Journal
Volume 156, Issue 6 , Pages 1196-1200, December 2008

Article Tools

* Image Usage & Resolution